77 results
Page 4 of 4
6-K
EX-99.1
rmev27v4q 7o
23 May 19
Current report (foreign)
8:00am
6-K
EX-99.1
h7rrlc6c
8 May 19
IFX-1 C5a Controlling inflammation Corporate Presentation May 2019
6:02am
20-F/A
p35a 31o2i
29 Mar 19
Annual report (foreign) (amended)
4:23pm
F-3ASR
yr53 0k0n
28 Mar 19
Automatic shelf registration (foreign)
9:09am
6-K
EX-99.1
ooy zjiu6udl
28 Mar 19
InflaRx Full Year 2018 Financial & Operating Results
8:48am
6-K
EX-99.1
ohd 7ju9ky
6 Feb 19
InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa
8:35am
6-K
EX-99.3
6ki8ti39pnad21pw5
21 Nov 18
Current report (foreign)
8:34am
6-K
EX-99.1
v577s
21 Nov 18
Current report (foreign)
8:34am
6-K
EX-99.1
chpsmefcuv 8bhrh
8 Nov 18
InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa
8:52am
6-K
EX-99.1
m3hbg3qyy712 1j6
9 Aug 18
Current report (foreign)
7:35am
6-K
EX-99.3
8a4m zmngp9
9 Aug 18
Current report (foreign)
7:35am
6-K
EX-99.1
9bkl0b3
17 May 18
Current report (foreign)
7:45am
424B4
24n7ls0w4a0d 6qt
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
0478b2 7x
2 May 18
Registration statement (foreign)
7:10am
F-1
EX-1.1
sfhe24i0v85
2 May 18
Registration statement (foreign)
7:10am
20-F
zh31wb p1
29 Mar 18
Annual report (foreign)
12:00am